Request a free sample copy in PDF or view the report [email protected] https://www.expertmarketresearch.com/reports/radiopharmaceuticals-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
- Historical Market Size (2020): About USD 4.3 billion
- Forecast CAGR (2022-2027): 7.5%
The growing market of radiopharmaceuticals is being led by a significant share held by North America. This can be ascribed to the presence of leading market players and well-funded research facilities in the region. With regular advances in the healthcare sector, the region is likely to maintain dominance in the coming years as well. Further, on the basis of region, the Asia Pacific region is anticipated to grow at a significant pace during the forecast period. Furthermore, owing to the commonality of thyroid-related disorders, the SPECT segment among the diagnostic radiopharmaceuticals is anticipated to propel the market during the forecast period. Moreover, with the year-by-year rise in cancer patients, the oncology segment is expected to witness significant growth in the coming years, thereby contributing to the market growth.
Industry Definition and Segmentation
A radiopharmaceutical is defined as a group of pharmaceutical drugs that contains radioisotopes. Also known as medicinal radiocompounds, radiopharmaceuticals can be used as a diagnosis medication as well as a therapeutic agent for both chronic and critical diseases.
Explore the full report with the table of [email protected] https://www.expertmarketresearch.com/reports/radiopharmaceuticals-market
Based on generators type, the market can be segmented into:
- W-188/Re-188 Generators
- Mo-99/Tc-99m Generators
- Sr-82/Rb-82 Generators
- Sr-90/Y-90 Generators
- Ge-68/Ga-67,68 Generators
On the basis application, the market can be divided into:
- Diagnostic Radiopharmaceuticals
- SPECT (Single-Photon Emission Computed Tomography)
- PET (Positron Emission Tomography)
- Therapeutic Radiopharmaceuticals
- Cardiology and Neurology
The major end use segments of radiopharmaceuticals are:
- Diagnostic Centres
The regional markets for radiopharmaceuticals include:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The radiopharmaceutical segment is the fastest-growing segment of the overall pharmaceutical industry. This can be associated with the rising demand for timely diagnostics and treatment of diseases owing to the increasing prevalence of chronic and fatal disorders. As a result, the revolutionary utilisation of radiopharmaceuticals in diagnostics is gaining popularity in the healthcare sector. Furthermore, the rising acceptance of disease-specific therapy, enhanced patient awareness regarding accurate and timely diagnosis, and expanding applications of molecular imaging are additional factors invigorating the growth of radiopharmaceuticals.
Key Market Players
The major players in the market are Jubilant Pharma Holdings Inc., Clarity Pharmaceuticals, and Cardinal Health, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
Company Name: EMR Inc.
Contact Person: Steven Luke, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Country: United States
Also, Check Procurement Intelligence which provides you with Infallible research solutions.
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.